I've had the same issues Beach...the Faro's have shown N-Assay to have great abilities and capabilities. With the presentations and publications N-Assay has been demonstrated to be awesome. My 64 thousand dollar question is if it is as good as we think it is, why hasn't NNLX been approached by larger, well established companies to either market and distribute the product or partner with NNLX for the production of N-Assay. This product can save many lives.

Is it a question of visibility? Are larger companies not being approached by NNLX for production, marketing, or sales? I'm sure the CEO has the shareholders interest at heart but at some point some form of assistance needs to occur or IMO NNLX will not survive. I honestly thought we would get some good news in these areas by the end of the year. I know it takes time but it's been quite some time since the Faro's presentation and the publication. The SP has drifted back to the 3's and 4's as I thought it would and will stay there until we get some good news...2018 is fast approaching.